Why the study?
Most intensive care unit patients with acute myocardial infarction go unrecognised, highlighting the need to explore guidelines and troponin research for diagnosis and prognosis.
Does troponin testing improve the diagnosis and risk stratification of myocardial infarction in critically ill patients?
Does troponin testing improve the diagnosis and risk stratification of myocardial infarction in critically ill patients?
While routine troponin testing is not recommended for all ICU patients, targeted testing in those with pre-existing cardiovascular disease may help identify under-diagnosed type 2 myocardial infarction and potentially improve outcomes.
MI underrecognized in ICU despite mortality link; leaves open troponin thresholds and management for supply-demand mismatch.
Myocardial infarction is common in the critically unwell population with pre-existing cardiovascular disease and is associated with a greater overall mortality. This article explores guidelines for diagnosing myocardial infarction, and research into the use of troponin as both a diagnostic and prognostic tool. Currently, the majority of patients in the intensive care unit with acute myocardial infarction go unrecognised. The underlying cause is predominantly oxygen supply-demand imbalance, therefore identifying those at risk is important as there is the potential to modify elements of their care and reduce their overall mortality.
No takes yet. Share an insight, caveat, or question.
Cole et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: